Breaking News, Trials & Filings

Fujifilm Diosynth Biotechnologies Unveils Strategic Customer-Focused Business Structure

New unit to provide tailored support to large-and small-scale biopharmaceutical customers.

FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, disclosed a new strategic business unit (SBU) structure to provide tailored support to large- and small-scale biopharmaceutical customers with high quality service and world-class performance by aligning unique service offerings and manufacturing capacities. The large-scale SBU is designed to meet the needs of clients who need acce...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters